Kano Therapeutics Inc.
Cambridge, MA
- UEI
- F7V8VC1CZQT6
- CAGE
- 9ZKG3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 700 Main St, Cambridge, MA 02139, USA
- Website
- kanotherapeutics.com
- Founded
- 2021
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Active non-viral nuclear delivery of DNA templates independent of mitosis | National Institute of General Medical Sciences (NIH) | $1,334,233 |
Quick answers
Is Kano Therapeutics Inc. registered in SAM.gov?
Yes. Kano Therapeutics Inc.'s SAM.gov registration is active through June 24, 2027.
What is Kano Therapeutics Inc.'s most recent federal award?
Kano Therapeutics Inc.'s most recent federal grant award is Active non-viral nuclear delivery of DNA templates independent of mitosis (R44GM159495), from National Institute of General Medical Sciences (NIH), on September 1, 2025.
On GovTribe
See Kano Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors